Henry M. Jackson Foundation for the Advancement of Military Medicine

Advancing Military Medicine

Search Results - oncogene

2 Results Sort By:
Small Molecule Targeted Therapeutics for Breast Cancer - (HJF 533-19)
A technology related to using novel small molecule therapeutics for breast cancer treatment is available for licensing from HJF. These small molecules specifically inhibit LY6K, a cancer-testis oncoprotein, in cancer cells, thus providing a novel targeted therapy for breast, colorectal, and other cancers. Applications and Advantages Targeted therapeutics...
Published: 10/17/2024   |   Updated: 1/23/2023   |   Inventor(s): Geeta Upadhyay
Keywords(s): Breast Cancer, Cancer, Colorectal Cancer, LY6K, Oncogene, Small Molecule, Therapeutics
Category(s): Therapeutic
Small Molecule Inhibitors of ERG Oncoprotein - (HJF 578-20, HJF 393-15, and HJF 324-13)
HJF scientists have developed a first-in-class family of novel and potent small molecule ERG inhibitors that can be used as targeted therapeutics for malignant diseases with overexpression of ERG oncoproteins. Therapeutic indications may include prostate cancer, leukemia, and colorectal cancer. Applications and Advantages First-in-class small molecule...
Published: 10/17/2024   |   Updated: 3/8/2022   |   Inventor(s): Albert Dobi, Sanjay Malhotra, Mallesh Pandrala, Binil Eldhose
Keywords(s): Cancer, Colorectal Cancer, ERG, Leukemia, Oncogene, Prostate Cancer, Small Molecule, Therapeutics
Category(s): Therapeutic